Iowa State Bank’s Bristol-Myers Squibb BMY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$1.85M Sell
30,428
-16,370
-35% -$954K 0.34% 76
2025
Q4
$2.52M Sell
46,798
-2,084
-4% -$100K 0.47% 60
2025
Q3
$2.2M Sell
48,882
-322
-0.7% -$15K 0.42% 67
2025
Q2
$2.28M Sell
49,204
-1,271
-3% -$62.4K 0.45% 67
2025
Q1
$3.08M Buy
50,475
+3,542
+8% +$206K 0.65% 50
2024
Q4
$2.65M Buy
46,933
+48
+0.1% +$2.68K 0.55% 58
2024
Q3
$2.43M Buy
46,885
+9,354
+25% +$439K 0.5% 65
2024
Q2
$1.56M Sell
37,531
-2,424
-6% -$108K 0.34% 77
2024
Q1
$2.17M Sell
39,955
-18,411
-32% -$938K 0.48% 70
2023
Q4
$2.99M Sell
58,366
-12
-0% -$630 0.72% 51
2023
Q3
$3.39M Sell
58,378
-502
-0.9% -$30.8K 0.88% 39
2023
Q2
$3.77M Sell
58,880
-1,087
-2% -$72.9K 0.95% 34
2023
Q1
$4.16M Sell
59,967
-5,832
-9% -$411K 1.04% 31
2022
Q4
$4.73M Buy
65,799
+452
+0.7% +$34.1K 1.19% 26
2022
Q3
$4.64M Buy
65,347
+248
+0.4% +$18K 1.32% 25
2022
Q2
$5.01M Sell
65,099
-531
-0.8% -$40.4K 1.33% 25
2022
Q1
$4.79M Sell
65,630
-938
-1% -$63K 1.11% 30
2021
Q4
$4.15M Buy
66,568
+805
+1% +$47.2K 0.98% 35
2021
Q3
$3.89M Buy
65,763
+433
+0.7% +$28.5K 1.09% 32
2021
Q2
$4.37M Sell
65,330
-460
-0.7% -$30K 1.23% 27
2021
Q1
$4.15M Buy
65,790
+1,175
+2% +$73.1K 1.25% 26
2020
Q4
$4.01M Buy
64,615
+1,441
+2% +$88.6K 1.33% 25
2020
Q3
$3.81M Buy
63,174
+5,765
+10% +$347K 1.47% 22
2020
Q2
$3.38M Sell
57,409
-1,312
-2% -$78.5K 1.47% 25
2020
Q1
$3.27M Sell
58,721
-192
-0.3% -$11.7K 1.54% 21
2019
Q4
$3.78M Buy
58,913
+1,288
+2% +$73.8K 1.34% 28
2019
Q3
$2.92M Buy
57,625
+3,089
+6% +$145K 1.11% 33
2019
Q2
$2.47M Buy
54,536
+688
+1% +$32K 1.1% 33
2019
Q1
$2.57M Buy
53,848
+950
+2% +$47.3K 1.18% 33
2018
Q4
$2.75M Buy
52,898
+742
+1% +$39.9K 1.39% 29
2018
Q3
$3.24M Buy
52,156
+579
+1% +$34.4K 1.44% 30
2018
Q2
$2.85M Buy
51,577
+45
+0.1% +$2.43K 1.36% 31
2018
Q1
$3.26M Sell
51,532
-2,308
-4% -$148K 1.59% 27
2017
Q4
$3.3M Buy
53,840
+144
+0.3% +$9.01K 1.49% 28
2017
Q3
$3.42M Buy
53,696
+466
+0.9% +$27.2K 1.61% 28
2017
Q2
$2.97M Buy
53,230
+1,675
+3% +$91.1K 1.42% 34
2017
Q1
$2.8M Buy
51,555
+1,970
+4% +$108K 1.37% 35
2016
Q4
$2.9M Sell
49,585
-725
-1% -$39.6K 1.49% 32
2016
Q3
$2.71M Sell
50,310
-2,887
-5% -$185K 1.45% 35
2016
Q2
$3.91M Buy
53,197
+522
+1% +$36.9K 2.12% 22
2016
Q1
$3.37M Sell
52,675
-1,076
-2% -$67.9K 1.9% 25
2015
Q4
$3.7M Buy
53,751
+2,165
+4% +$143K 2.19% 24
2015
Q3
$3.05M Sell
51,586
-665
-1% -$42.2K 2.09% 23
2015
Q2
$3.48M Sell
52,251
-260
-0.5% -$17.1K 2.19% 23
2015
Q1
$3.39M Sell
52,511
-180
-0.3% -$11.3K 2.15% 23
2014
Q4
$3.11M Sell
52,691
-1,005
-2% -$56.7K 1.96% 24
2014
Q3
$2.75M Buy
53,696
+250
+0.5% +$12.5K 1.84% 27
2014
Q2
$2.59M Buy
53,446
+430
+0.8% +$21.2K 1.75% 29
2014
Q1
$2.75M Buy
53,016
+1,250
+2% +$66.5K 1.96% 27
2013
Q4
$2.75M Sell
51,766
-2,230
-4% -$114K 2.02% 26
2013
Q3
$2.5M Buy
53,996
+6,460
+14% +$284K 1.96% 26
2013
Q2
$2.12M Buy
+47,536
New +$2.06M 1.75% 26

Other funds holding BMY

Iowa State Bank's BMY Position: Q1 2026 in Review

Iowa State Bank reduced its Bristol-Myers Squibb (BMY) stake by 35% in Q1 2026, selling an estimated $954K and leaving 30,428 shares worth $1.85M. The position accounts for 0.34% of the portfolio, ranked #76.

Iowa State Bank first reported a position in BMY in Q2 2013 and has held it in 52 quarters since. The position peaked at $5.01M in Q2 2022. 2,520 funds tracked by Wall St. Rank hold BMY as of Q1 2026.

  • Iowa State Bank held 30,428 shares of Bristol-Myers Squibb worth $1.85M as of Q1 2026.
  • Iowa State Bank sold 16,370 Bristol-Myers Squibb shares in Q1 2026, an estimated $954K.
  • Bristol-Myers Squibb made up 0.34% of Iowa State Bank's portfolio in Q1 2026, its #76 holding.
  • Iowa State Bank first reported a position in Bristol-Myers Squibb in Q2 2013 and has held it in 52 quarters since.
  • Iowa State Bank's Bristol-Myers Squibb position peaked at $5.01M in Q2 2022.
  • 2,520 funds tracked by Wall St. Rank held Bristol-Myers Squibb as of Q1 2026.

Based on Iowa State Bank's 13F filing for Q1 2026, filed 15 Apr 2026.